论文部分内容阅读
目的:探讨无创双水平气道正压通气治疗不同病因致急性呼吸衰竭的疗效。方法:挑选2014年4月-2016年4月我院所收治的80例急性呼吸衰竭患者作为研究对象,依据病因的不同,分成对照组(重症肺炎)与观察组(心源性肺水肿),每组40例。两组都执行无创双水平气道正压通气治疗,对比分析两组治疗效果。结果:对比两组动脉血气指标,观察组明显比对照组更优,差异有统计学意义(P<0.05)。对比两组无创双水平正压通气治疗时间、症状改善时长、住院时长、气管插管出现机率,观察组明显比对照组更优,差异有统计学意义(P<0.05)。结论:运用无创双水平气道正压通气治疗由心源性肺水肿与重症肺炎所引发的急性呼吸衰竭,有明显治疗效果,值得大力推广应用。
Objective: To investigate the efficacy of noninvasive bi-level positive airway pressure ventilation in treating acute respiratory failure with different causes. Methods: Eighty patients with acute respiratory failure treated in our hospital from April 2014 to April 2016 were selected as the research object. According to the cause, the patients were divided into control group (severe pneumonia) and observation group (cardiogenic pulmonary edema) 40 cases in each group. Two groups were performed non-invasive bi-level positive airway pressure treatment, comparative analysis of two groups of treatment. Results: Comparing the two groups of arterial blood gas indicators, the observation group was significantly better than the control group, the difference was statistically significant (P <0.05). Comparing the two groups of non-invasive bi-level positive pressure ventilation treatment time, symptom improvement time, length of hospital stay, tracheal intubation probability, the observation group was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion: The use of non-invasive bi-level positive airway pressure in the treatment of acute respiratory failure caused by cardiogenic pulmonary edema and severe pneumonia has obvious curative effect and is worth popularization and application.